Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients
Completed
- Conditions
- AnemiaCardiac SurgeryIntensive Care
- Registration Number
- NCT00338234
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation.
- Detailed Description
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation. The latter is known to interfere with iron metabolism, inducing iron storage instead of using it for hemoglobin synthesis. The discover of a new regulatory hormone of iron metabolism, hepcidin, may help us to better understand the link between inflammation and iron functional deficit. The aim of our study is to observe the variation of usual iron metabolism biological markers and of hepcidin, in order to define the better marker of iron loss in these clinical situations.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 153
Inclusion Criteria
- Anemia (haemoglobin < 10 g/dL)
- Hospitalization in ICU for an expected duration of 7 days or more
- Or, day one post cardiac surgery
Read More
Exclusion Criteria
- Chronic anemia (Hb < 9 g/dL for more than one month before hospitalization)
- Iron metabolism disease
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional iron deficiency during the study
- Secondary Outcome Measures
Name Time Method fatigue assessed by the MFI20 score for cardiac surgery patients at one day,at seven days and at 28 days
Trial Locations
- Locations (1)
APHP, hopital Bichat
🇫🇷Paris, France